Examkin

Question

Difficulty: MediumGynecologic Oncology

Match each patient's clinical presentation with the most appropriate next step in diagnosis or management.

  • 65-year-old woman presenting with postmenopausal bleeding and an endometrial thickness of 3 mm on transvaginal ultrasoundReassurance and observation without immediate tissue sampling
  • 62-year-old woman presenting with postmenopausal bleeding and an endometrial thickness of 8 mm on transvaginal ultrasoundPrompt office endometrial biopsy to rule out malignancy
  • 38-year-old woman whose routine cervical cytology reports atypical glandular cells (AGC)Colposcopy, endocervical curettage, and endometrial biopsy
  • 48-year-old woman diagnosed with complex atypical endometrial hyperplasia who has completed childbearingTotal extrafascial hysterectomy with bilateral salpingo-oophorectomy
  • 29-year-old woman diagnosed with grade 1, stage IA endometrial adenocarcinoma who desires to preserve fertilityHigh-dose progestin therapy with serial endometrial sampling

Answer

The 65-year-old with a 3-mm stripe is matched with reassurance and observation. The 62-year-old with an 8-mm stripe requires an office endometrial biopsy. The 38-year-old with AGC requires colposcopy, endocervical curettage, and endometrial biopsy. The 48-year-old with atypical hyperplasia is treated with hysterectomy and bilateral salpingo-oophorectomy. The 29-year-old with early-stage cancer desiring fertility is matched with high-dose progestin therapy.
Gynecologic oncology guidelines rely heavily on risk stratification based on age, imaging findings, and biopsy results. In postmenopausal bleeding, ultrasound is an effective triage tool: a stripe ≤ 4 mm requires no further intervention, whereas > 4 mm mandates biopsy. Atypical glandular cells on a Pap smear present a risk for both cervical and endometrial malignancies, requiring dual evaluation in women 35 and older. Definitive management of atypical hyperplasia is hysterectomy due to cancer risk, but early-grade cancers in young women can be medically suppressed with progestins to preserve fertility.

Step-by-Step Solution

1
Evaluate the 65-year-old with postmenopausal bleeding and a 3-mm endometrial stripe.
Observation is indicated.
An endometrial thickness of 4 mm or less reliably rules out endometrial cancer in postmenopausal women with bleeding.
2
Evaluate the 62-year-old with postmenopausal bleeding and an 8-mm stripe.
Endometrial biopsy is indicated.
An endometrial thickness > 4 mm in a postmenopausal woman is abnormal and requires histologic evaluation.
3
Assess the 38-year-old with AGC on her Pap smear.
Colposcopy, ECC, and endometrial biopsy are indicated.
AGC can originate from the cervix or the endometrium; all women 35 and older with AGC require comprehensive sampling of both areas.
4
Determine the management for the 48-year-old with atypical hyperplasia who has finished childbearing.
Total hysterectomy with bilateral salpingo-oophorectomy is indicated.
This is a precancerous lesion with a high rate of progression to malignancy, making definitive surgical management the standard of care.
5
Formulate a plan for the 29-year-old with grade 1 endometrial cancer.
High-dose progestins are indicated.
Highly motivated young women with early, well-differentiated disease can use medical management to preserve the uterus for future childbearing.

Key Concept

Evidence-based management of abnormal uterine bleeding, cervical cytology abnormalities, and endometrial neoplasia based on patient risk factors.
Rate this question

Topics

Gynecologic Oncology

More questions from this topic